Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 PneumoniaCarlo Salvarani|JAMA Internal Medicine|2020Cited by 732
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational studyMario Messina, Giacomo Emmi, Marco Cattalini et al.|Clinical Rheumatology|2018Cited by 82
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF-<i>α</i> Receptor—Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA NetworkCarla Gaggiano, Luca Cantarini, Antonio Vitale et al.|Mediators of Inflammation|2020Cited by 49
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Luca Cantarini, Donato Rigante et al.|Frontiers in Pharmacology|2019Cited by 45